by Donna Vanderpool, MBA, JD Ms. Vanderpool is Director of Risk Management at Professional Risk Management Services (PRMS) FUNDING: No funding was provided for the preparation of this article. DISCLOSURES:
Dear Colleagues: Welcome to the July–September 2020 edition of Innovations in Clinical Neuroscience (ICNS). For 2020’s third quarterly issue of ICNS, we start with two letters to the editor. First,
by Rocco Salvatore Calabrò MD, PhD; Carmela Casella, MD; Alfredo Manuli, MSc; David Militi, MD; and Giuseppe Gervasi, MD, PhD Drs. Calabrò and Manuli are with IRCCS Centro Neurolesi “Bonino
by Danielle Gainer, MD; Sarah Alam, BS; Harris Alam; and Hannah Redding, BA Dr. Gainer, Sarah Alam, and Ms. Redding are with Wright State University Boonshoft School of Medicine in
by Hissei Imai, MD, PhD; Mitsuhiko Yamada, MD, PhD; Masatoshi Inagaki, MD, PhD; Norio Watanabe, MD, PhD; Bun Chino, MD, PhD; Akio Mantani, MD, PhD; and Toshiaki A Furukawa, MD,
by Vishwanath Sagi MBBS, MPH; Jaime Shoup MD; Ravikiran Chilukuri; and M. Steven Evans MD Drs. Sagi and Evans are with the Department of Neurology at the University of Louisville